PumasAI launches four-part webinar series for AI-powered PK analysis

PumasAI is rolling out PumasCP End-to-End, a four-session webinar series starting September 2, 2026, to show clinical pharmacology teams how to move from raw data to regulatory-ready reporting in one reproducible workflow. The launch follows PumasCP 3.9, which adds new visualization tools for publication-quality and regulatory plots.

Why it matters: - Clinical pharmacology teams are under pressure to move faster without sacrificing reproducibility or regulatory readiness. - PumasAI is positioning AI-assisted workflows as a way to reduce handoffs across PK analysis, visualization and reporting. - The series targets scientists who need a practical path from raw concentration data to submission-ready documentation.

What happened: - PumasAI announced PumasCP End-to-End, a four-part educational webinar series for clinical pharmacology professionals. - The series begins September 2, 2026, with follow-up sessions on September 9, September 16 and September 23. - Registration is available through the webinar page.

The details: - Session A covers data import, wrangling, CDISC-aligned ADNCA construction and agent-assisted data preparation. - Session B focuses on noncompartmental analysis, bioequivalence, dose proportionality and superposition analyses. - Session C shows how to create pharmacokinetic figures with built-in templates and custom visualization tools. - Session D walks through assembling tables, figures, listings and report narratives into a reproducible PK clinical study report. - Each session includes a live demonstration and an “Agent Spotlight” segment. - PumasAI says the series is designed for clinical pharmacologists, PK/PD scientists, pharmacometricians, quantitative scientists, regulatory professionals and biostatisticians. - Dr. Vijay Ivaturi, PumasAI co-founder and CEO, said the goal is to help teams eliminate unnecessary handoffs, improve reproducibility and spend more time interpreting science. - Dr. Ivaturi also said bringing data preparation, analysis, visualization and reporting into one environment can improve consistency and accelerate timelines. - The webinar series shows how PumasAI's intelligent agents can assist with workflow steps while scientists keep control of decisions.

Between the lines: - The launch reinforces a broader shift toward unified clinical pharmacology platforms that combine automation with human oversight. - PumasAI is linking the webinar series to the release of PumasCP 3.9, suggesting the events will also serve as product education. - The company is emphasizing reproducibility and regulatory readiness, not just speed, which matters for teams working on submission-bound studies.

What's next: - The first session is scheduled for September 2, 2026. - Additional sessions will follow weekly through September 23, 2026. - PumasAI says each session will include demonstrations of agent capabilities inside PumasCP. - The company also says PumasCP 3.9 adds Advanced Figure support for more publication-quality and regulatory-ready plots. - The platform now supports concentration-over-time visualizations, summary plots, box plots, violin plots, density plots and histograms. - PumasCP 3.9 also adds company-standard themes and styling to keep presentation consistent across analysis and reporting.

The bottom line: - PumasAI is using the webinar series to showcase PumasCP as an end-to-end environment for AI-assisted PK analysis, report generation and regulatory workflows.